ArticleEClinicalMedicine2026

The effect of SGLT2 inhibitors, GLP-1 receptor agonists, or DPP-4 inhibitors on stroke risk in type 2 diabetes: a nationwide longitudinal cohort study in Sweden with contextualisation analysis.

Anastasios Mavridis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.